Indaptus Therapeutics, Inc.INDPNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank43
Year-over-Year Change
Year-over-year research & development expense growth
Percentile
P43
Within normal range
vs 2Y Ago
0x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -4.86% |
| 2023 | 20.51% |
| 2022 | 150.66% |
| 2021 | -4.97% |
| 2020 | -90.04% |
| 2019 | -24.70% |
| 2018 | 45.72% |
| 2017 | 141.19% |
| 2016 | 146.46% |
| 2015 | -6.99% |